High Central Pulse Pressure Is Independently Associated With Adverse Cardiovascular Outcome. The Strong Heart Study

Mary J. Roman, Richard B. Devereux, Jorge Kizer, Peter M. Okin, Elisa T. Lee, Wenyu Wang, Jason G. Umans, Darren Calhoun, Barbara V. Howard

Research output: Contribution to journalArticle

197 Citations (Scopus)

Abstract

Objectives: This study was designed to facilitate clinical use of central pulse pressure (PP). We sought to determine a value that might predict adverse outcome and thereby provide a target for assessment of intervention strategies. Background: We previously documented that central PP more strongly relates to carotid hypertrophy and extent of atherosclerosis and, more importantly, better predicts incident cardiovascular disease (CVD) than brachial PP. Methods: Radial applanation tonometry was performed in the third Strong Heart Study examination to determine central blood pressure. Cox regression analyses were performed using pre-specified covariates and quartiles of central and brachial PP. Results: Among 2,405 participants without prevalent CVD, 344 suffered CVD events during 5.6 ± 1.7 years. Quartiles of central PP (p < 0.001) predicted outcome more strongly than quartiles of brachial PP (p = 0.052). With adjustment for covariates, only the event rate in the fourth quartile of central PP (≥50 mm Hg) was significantly higher than that in the first quartile (hazard ratio [HR]: 1.69, 95% confidence interval [CI]: 1.20 to 2.39, p = 0.003). Central PP ≥50 mm Hg was related to outcome in both men (HR: 2.06, 95% CI: 1.39 to 3.04, p < 0.001) and women (HR: 2.03, 95% CI: 1.55 to 2.65, p < 0.001); in participants with (HR: 1.84, 95% CI: 1.41 to 2.39, p < 0.001) and without diabetes (HR: 1.91, 95% CI: 1.29 to 2.83, p = 0.001); and in individuals younger (HR: 2.51, 95% CI: 1.59 to 3.95, p < 0.001) and older (HR: 1.53, 95% CI: 1.19 to 1.97, p = 0.001) than the age of 60 years. Conclusions: Central PP ≥50 mm Hg predicts adverse CVD outcome and may serve as a target in intervention strategies if confirmed in other populations and in prospective studies.

Original languageEnglish (US)
Pages (from-to)1730-1734
Number of pages5
JournalJournal of the American College of Cardiology
Volume54
Issue number18
DOIs
StatePublished - Oct 27 2009
Externally publishedYes

Fingerprint

Blood Pressure
Confidence Intervals
Cardiovascular Diseases
Arm
Manometry
Hypertrophy
Atherosclerosis
Regression Analysis
Prospective Studies
Population

Keywords

  • blood pressure determination
  • detection and control
  • elasticity
  • hypertension
  • vasculature

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

High Central Pulse Pressure Is Independently Associated With Adverse Cardiovascular Outcome. The Strong Heart Study. / Roman, Mary J.; Devereux, Richard B.; Kizer, Jorge; Okin, Peter M.; Lee, Elisa T.; Wang, Wenyu; Umans, Jason G.; Calhoun, Darren; Howard, Barbara V.

In: Journal of the American College of Cardiology, Vol. 54, No. 18, 27.10.2009, p. 1730-1734.

Research output: Contribution to journalArticle

Roman, Mary J. ; Devereux, Richard B. ; Kizer, Jorge ; Okin, Peter M. ; Lee, Elisa T. ; Wang, Wenyu ; Umans, Jason G. ; Calhoun, Darren ; Howard, Barbara V. / High Central Pulse Pressure Is Independently Associated With Adverse Cardiovascular Outcome. The Strong Heart Study. In: Journal of the American College of Cardiology. 2009 ; Vol. 54, No. 18. pp. 1730-1734.
@article{79e31db982e54d538ed9fb191efa6a6b,
title = "High Central Pulse Pressure Is Independently Associated With Adverse Cardiovascular Outcome. The Strong Heart Study",
abstract = "Objectives: This study was designed to facilitate clinical use of central pulse pressure (PP). We sought to determine a value that might predict adverse outcome and thereby provide a target for assessment of intervention strategies. Background: We previously documented that central PP more strongly relates to carotid hypertrophy and extent of atherosclerosis and, more importantly, better predicts incident cardiovascular disease (CVD) than brachial PP. Methods: Radial applanation tonometry was performed in the third Strong Heart Study examination to determine central blood pressure. Cox regression analyses were performed using pre-specified covariates and quartiles of central and brachial PP. Results: Among 2,405 participants without prevalent CVD, 344 suffered CVD events during 5.6 ± 1.7 years. Quartiles of central PP (p < 0.001) predicted outcome more strongly than quartiles of brachial PP (p = 0.052). With adjustment for covariates, only the event rate in the fourth quartile of central PP (≥50 mm Hg) was significantly higher than that in the first quartile (hazard ratio [HR]: 1.69, 95{\%} confidence interval [CI]: 1.20 to 2.39, p = 0.003). Central PP ≥50 mm Hg was related to outcome in both men (HR: 2.06, 95{\%} CI: 1.39 to 3.04, p < 0.001) and women (HR: 2.03, 95{\%} CI: 1.55 to 2.65, p < 0.001); in participants with (HR: 1.84, 95{\%} CI: 1.41 to 2.39, p < 0.001) and without diabetes (HR: 1.91, 95{\%} CI: 1.29 to 2.83, p = 0.001); and in individuals younger (HR: 2.51, 95{\%} CI: 1.59 to 3.95, p < 0.001) and older (HR: 1.53, 95{\%} CI: 1.19 to 1.97, p = 0.001) than the age of 60 years. Conclusions: Central PP ≥50 mm Hg predicts adverse CVD outcome and may serve as a target in intervention strategies if confirmed in other populations and in prospective studies.",
keywords = "blood pressure determination, detection and control, elasticity, hypertension, vasculature",
author = "Roman, {Mary J.} and Devereux, {Richard B.} and Jorge Kizer and Okin, {Peter M.} and Lee, {Elisa T.} and Wenyu Wang and Umans, {Jason G.} and Darren Calhoun and Howard, {Barbara V.}",
year = "2009",
month = "10",
day = "27",
doi = "10.1016/j.jacc.2009.05.070",
language = "English (US)",
volume = "54",
pages = "1730--1734",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "18",

}

TY - JOUR

T1 - High Central Pulse Pressure Is Independently Associated With Adverse Cardiovascular Outcome. The Strong Heart Study

AU - Roman, Mary J.

AU - Devereux, Richard B.

AU - Kizer, Jorge

AU - Okin, Peter M.

AU - Lee, Elisa T.

AU - Wang, Wenyu

AU - Umans, Jason G.

AU - Calhoun, Darren

AU - Howard, Barbara V.

PY - 2009/10/27

Y1 - 2009/10/27

N2 - Objectives: This study was designed to facilitate clinical use of central pulse pressure (PP). We sought to determine a value that might predict adverse outcome and thereby provide a target for assessment of intervention strategies. Background: We previously documented that central PP more strongly relates to carotid hypertrophy and extent of atherosclerosis and, more importantly, better predicts incident cardiovascular disease (CVD) than brachial PP. Methods: Radial applanation tonometry was performed in the third Strong Heart Study examination to determine central blood pressure. Cox regression analyses were performed using pre-specified covariates and quartiles of central and brachial PP. Results: Among 2,405 participants without prevalent CVD, 344 suffered CVD events during 5.6 ± 1.7 years. Quartiles of central PP (p < 0.001) predicted outcome more strongly than quartiles of brachial PP (p = 0.052). With adjustment for covariates, only the event rate in the fourth quartile of central PP (≥50 mm Hg) was significantly higher than that in the first quartile (hazard ratio [HR]: 1.69, 95% confidence interval [CI]: 1.20 to 2.39, p = 0.003). Central PP ≥50 mm Hg was related to outcome in both men (HR: 2.06, 95% CI: 1.39 to 3.04, p < 0.001) and women (HR: 2.03, 95% CI: 1.55 to 2.65, p < 0.001); in participants with (HR: 1.84, 95% CI: 1.41 to 2.39, p < 0.001) and without diabetes (HR: 1.91, 95% CI: 1.29 to 2.83, p = 0.001); and in individuals younger (HR: 2.51, 95% CI: 1.59 to 3.95, p < 0.001) and older (HR: 1.53, 95% CI: 1.19 to 1.97, p = 0.001) than the age of 60 years. Conclusions: Central PP ≥50 mm Hg predicts adverse CVD outcome and may serve as a target in intervention strategies if confirmed in other populations and in prospective studies.

AB - Objectives: This study was designed to facilitate clinical use of central pulse pressure (PP). We sought to determine a value that might predict adverse outcome and thereby provide a target for assessment of intervention strategies. Background: We previously documented that central PP more strongly relates to carotid hypertrophy and extent of atherosclerosis and, more importantly, better predicts incident cardiovascular disease (CVD) than brachial PP. Methods: Radial applanation tonometry was performed in the third Strong Heart Study examination to determine central blood pressure. Cox regression analyses were performed using pre-specified covariates and quartiles of central and brachial PP. Results: Among 2,405 participants without prevalent CVD, 344 suffered CVD events during 5.6 ± 1.7 years. Quartiles of central PP (p < 0.001) predicted outcome more strongly than quartiles of brachial PP (p = 0.052). With adjustment for covariates, only the event rate in the fourth quartile of central PP (≥50 mm Hg) was significantly higher than that in the first quartile (hazard ratio [HR]: 1.69, 95% confidence interval [CI]: 1.20 to 2.39, p = 0.003). Central PP ≥50 mm Hg was related to outcome in both men (HR: 2.06, 95% CI: 1.39 to 3.04, p < 0.001) and women (HR: 2.03, 95% CI: 1.55 to 2.65, p < 0.001); in participants with (HR: 1.84, 95% CI: 1.41 to 2.39, p < 0.001) and without diabetes (HR: 1.91, 95% CI: 1.29 to 2.83, p = 0.001); and in individuals younger (HR: 2.51, 95% CI: 1.59 to 3.95, p < 0.001) and older (HR: 1.53, 95% CI: 1.19 to 1.97, p = 0.001) than the age of 60 years. Conclusions: Central PP ≥50 mm Hg predicts adverse CVD outcome and may serve as a target in intervention strategies if confirmed in other populations and in prospective studies.

KW - blood pressure determination

KW - detection and control

KW - elasticity

KW - hypertension

KW - vasculature

UR - http://www.scopus.com/inward/record.url?scp=70349990210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349990210&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2009.05.070

DO - 10.1016/j.jacc.2009.05.070

M3 - Article

C2 - 19850215

AN - SCOPUS:70349990210

VL - 54

SP - 1730

EP - 1734

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 18

ER -